Literature DB >> 22660719

Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae.

Alex R Hall1, Daniel De Vos, Ville-Petri Friman, Jean-Paul Pirnay, Angus Buckling.   

Abstract

Interest in using bacteriophages to treat bacterial infections (phage therapy) is growing, but there have been few experiments comparing the effects of different treatment strategies on both bacterial densities and resistance evolution. While it is established that multiphage therapy is typically more effective than the application of a single phage type, it is not clear if it is best to apply phages simultaneously or sequentially. We tried single- and multiphage therapy against Pseudomonas aeruginosa PAO1 in vitro, using different combinations of phages either simultaneously or sequentially. Across different phage combinations, simultaneous application was consistently equal or superior to sequential application in terms of reducing bacterial population density, and there was no difference (on average) in terms of minimizing resistance. Phage-resistant bacteria emerged in all experimental treatments and incurred significant fitness costs, expressed as reduced growth rate in the absence of phages. Finally, phage therapy increased the life span of wax moth larvae infected with P. aeruginosa, and a phage cocktail was the most effective short-term treatment. When the ratio of phages to bacteria was very high, phage cocktails cured otherwise lethal infections. These results suggest that while adding all available phages simultaneously tends to be the most successful short-term strategy, there are sequential strategies that are equally effective and potentially better over longer time scales.

Entities:  

Mesh:

Year:  2012        PMID: 22660719      PMCID: PMC3406105          DOI: 10.1128/AEM.00757-12

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  36 in total

Review 1.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

Authors:  S Ramaswamy; J M Musser
Journal:  Tuber Lung Dis       Date:  1998

2.  Generally overlooked fundamentals of bacterial genetics and ecology.

Authors:  Anne O Summers
Journal:  Clin Infect Dis       Date:  2002-06-01       Impact factor: 9.079

Review 3.  Bacteriophage resistance mechanisms.

Authors:  Simon J Labrie; Julie E Samson; Sylvain Moineau
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

4.  The phage therapy paradigm: prêt-à-porter or sur-mesure?

Authors:  Jean-Paul Pirnay; Daniel De Vos; Gilbert Verbeken; Maia Merabishvili; Nina Chanishvili; Mario Vaneechoutte; Martin Zizi; Geert Laire; Rob Lavigne; Isabelle Huys; Guy Van den Mooter; Angus Buckling; Laurent Debarbieux; Flavie Pouillot; Joana Azeredo; Elisabeth Kutter; Alain Dublanchet; Andrzej Górski; Revaz Adamia
Journal:  Pharm Res       Date:  2010-11-10       Impact factor: 4.200

5.  Hypermutability and compensatory adaptation in antibiotic-resistant bacteria.

Authors:  Gabriel G Perron; Alex R Hall; Angus Buckling
Journal:  Am Nat       Date:  2010-09       Impact factor: 3.926

6.  Epistasis buffers the fitness effects of rifampicin- resistance mutations in Pseudomonas aeruginosa.

Authors:  Alex R Hall; R Craig MacLean
Journal:  Evolution       Date:  2011-05-10       Impact factor: 3.694

Review 7.  Bacteriophages for the treatment of Pseudomonas aeruginosa infections.

Authors:  D R Harper; M C Enright
Journal:  J Appl Microbiol       Date:  2011-04-18       Impact factor: 3.772

8.  The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages.

Authors:  H W Smith; M B Huggins; K M Shaw
Journal:  J Gen Microbiol       Date:  1987-05

9.  Bacteriophage isolated from feedlot cattle can reduce Escherichia coli O157:H7 populations in ruminant gastrointestinal tracts.

Authors:  Todd R Callaway; Tom S Edrington; Andrew D Brabban; Robin C Anderson; Michelle L Rossman; Mike J Engler; Mandy A Carr; Ken J Genovese; James E Keen; Mike L Looper; Elizabeth M Kutter; David J Nisbet
Journal:  Foodborne Pathog Dis       Date:  2008-04       Impact factor: 3.171

10.  Bacteriophage therapy and the mutant selection window.

Authors:  Benjamin J Cairns; Robert J H Payne
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

View more
  55 in total

1.  Two Phages, phiIPLA-RODI and phiIPLA-C1C, Lyse Mono- and Dual-Species Staphylococcal Biofilms.

Authors:  Diana Gutiérrez; Dieter Vandenheuvel; Beatriz Martínez; Ana Rodríguez; Rob Lavigne; Pilar García
Journal:  Appl Environ Microbiol       Date:  2015-03-06       Impact factor: 4.792

Review 2.  Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections.

Authors:  Diana P Pires; Diana Vilas Boas; Sanna Sillankorva; Joana Azeredo
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

3.  Sublethal streptomycin concentrations and lytic bacteriophage together promote resistance evolution.

Authors:  Johannes Cairns; Lutz Becks; Matti Jalasvuori; Teppo Hiltunen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-01-19       Impact factor: 6.237

4.  Co-evolutionary dynamics of the bacteria Vibrio sp. CV1 and phages V1G, V1P1, and V1P2: implications for phage therapy.

Authors:  Camilo Barbosa; Patrick Venail; Angela V Holguin; Martha J Vives
Journal:  Microb Ecol       Date:  2013-09-08       Impact factor: 4.552

5.  Contrasted coevolutionary dynamics between a bacterial pathogen and its bacteriophages.

Authors:  Alex Betts; Oliver Kaltz; Michael E Hochberg
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

6.  Phages can constrain protist predation-driven attenuation of Pseudomonas aeruginosa virulence in multienemy communities.

Authors:  Ville-Petri Friman; Angus Buckling
Journal:  ISME J       Date:  2014-03-27       Impact factor: 10.302

Review 7.  Phage Therapy in the Era of Synthetic Biology.

Authors:  E Magda Barbu; Kyle C Cady; Bolyn Hubby
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

Review 8.  Evolutionary Ecology of Prokaryotic Immune Mechanisms.

Authors:  Stineke van Houte; Angus Buckling; Edze R Westra
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-13       Impact factor: 11.056

Review 9.  Ecological Therapeutic Opportunities for Oral Diseases.

Authors:  Anilei Hoare; Philip D Marsh; Patricia I Diaz
Journal:  Microbiol Spectr       Date:  2017-08

Review 10.  Biological challenges of phage therapy and proposed solutions: a literature review.

Authors:  Katherine M Caflisch; Gina A Suh; Robin Patel
Journal:  Expert Rev Anti Infect Ther       Date:  2019-12-02       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.